Brief: Veracyte Announces Third Quarter 2022 Financial Results
Nov 2 (Reuters) - Veracyte Inc VCYT.O :
* VERACYTE ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS
* VERACYTE INC Q3 REVENUE ROSE 25 PERCENT TO $75.6 MILLION
* VERACYTE INC - RAISING FULL-YEAR 2022 TOTAL REVENUE
EXPECTATIONS
TO $288 MILLION TO $293 MILLION
* VERACYTE INC - QTRLY NET LOSS PER COMMON SHARE, BASIC AND
DILUTED $0.12
Source text for Eikon: ID:nBw61lkd8a
Further company coverage: VCYT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Veracyte
See all newsU.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
U.S. STOCKS ON THE MOVE-Snowflake, Cboe, Oracle
US STOCKS ON THE MOVE-Veracyte, Staar Surgical, Corning
Veracyte gains on data supporting use of prostate cancer test to guide treatment decisions
Corrected: U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina